破格救心汤加减治疗慢性心力衰竭临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R541.6

基金项目:


Clinical Study on Modified Poge Jiuxin Tang for Chronic Heart Failure
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察破格救心汤加减治疗慢性心力衰竭(CHF) 的临床疗效及对患者超声心动图、血清N端脑钠肽前体(NT-proBNP)、白细胞介素-6(IL-6) 水平的影响。方法:采用随机数字表法将131 例CHF 气虚血瘀证患者分为观察组(66 例) 及对照组(65 例)。对照组给予常规对症治疗,观察组在对照组基础上给予破格救心汤加减治疗。比较2 组治疗前后中医证候积分、6 min 步行试验、Lee 氏心衰评分、生活质量综合评定量表(GQOLI-74) 评分、肿瘤坏死因子-α(TNF-α)、IL-6、NT-proBNP 水平及超声心动图指标[左室舒张末期内径(LVEDd)、左室收缩末期内径(LVESd)、左心室射血分数(LVEF)];并评价2 组临床疗效及不良反应发生情况。结果:观察组总有效率90.91%,高于对照组76.92%(P<0.05)。治疗后,2 组中医证候积分、Lee 氏心衰评分及NT-proBNP、IL-6、TNF-α 水平均治疗前降低(P<0.05),且观察组降低幅度大于对照组(P<0.05)。治疗后,2 组LVEDd、LVESd 值均较治疗前降低(P<0.05),LVEF 值升高(P<0.05),观察组心动图指标改善优于对照组(P<0.05)。治疗后,2 组6 min 步行距离及GQOLI-74 各项评分均较治疗前增加(P<0.05),且观察组上述指标改善优于对照组(P<0.05)。2 组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:破格救心汤加减治疗CHF 临床疗效确切,可改善患者心功能,减轻炎症反应,提高患者生活质量。

    Abstract:

    Abstract:Objective:To observe the clinical effect of modified Poge Jiuxin tang on chronic heart failure (CHF) and its effect on echocardiography,and levels of serum N-terminal pro-brain natriuretic peptide(NTproBNP), and interleukin-6(IL-6). Methods:A total of 131 CHF patients with qi deficiency and blood stasis syndrome were randomly divided into the observation group and the control group according to the random number table method, with 66 and 65 cases in each group respectively. The control group was given routine symptomatic treatment,and the observation group was additionally given modified Poge Jiuxin tang based on the treatment of the control group. Before and after treatment,the Chinese medicine syndrome scores,Six-Minute Walk Test,Lee's heart failure scores,scores of Generic Quality of Life Inventory-74 (GQOLI-74),levels of tumor necrosis factor-α(TNF-α),IL-6,and NT-proBNP,and echocardiographic indexes, including left ventricular end- diastolic diameter(LVEDd), left ventricular end- systolic diameter (LVESd),and left ventricular ejection fraction(LVEF),were compared between the two groups. The clinical effects and adverse reactions in the two groups were evaluated. Results: The total effective rate was 90.91% in the observation group, higher than that of 76.92% in the control group(P<0.05). After treatment, the Chinese medicine syndrome scores, Lee's heart failure scores, and levels of NTproBNP, IL-6,and TNF-α in the two groups were decreased when compared with those before treatment (P<0.05),and the decrease in the observation group was greater than that in the control group(P<0.05). after treatment,the levels of LVEDd and LVESd in the two groups were decreased when compared with those before treatment(P<0.05), the levels of LVEF were increased, and the improvements in echocardiography indexes in the observation group were better than those in the control group(P<0.05). After treatment, the six- minute walking distance and scores of GQOLI- 74 in the two groups were increased when compared with those before treatment(P<0.05), and the improvements in the above indexes in the observation group were better than those in the control group(P<0.05). There was no significant difference being found in the comparison of incidence of adverse reactions between the two groups(P>0.05). Conclusion: The therapy of modified Poge Jiuxin tang has a definite clinical effect on CHF,which can improve the heart function,reduce the inflammatory responses,and improve the quality of life of patients.

    参考文献
    相似文献
    引证文献
引用本文

蒋欢,邬燕萍,林韩立.破格救心汤加减治疗慢性心力衰竭临床研究[J].新中医,2022,54(13):36-40

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-07-07
  • 出版日期:
文章二维码